Online inquiry

IVTScrip™ mRNA-Human ANKRD65, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK16734MR)

This product GTTS-WK16734MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ANKRD65 protein. This product can be used in Ciliated cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001145210.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 441869
UniProt ID E5RJM6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD65, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK16734MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK26805MR IVTScrip™ mRNA-Human ARHGDIB, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGDIB
GTTS-WK26814MR IVTScrip™ mRNA-Human ARHGEF26, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF26
GTTS-WK19530MR IVTScrip™ mRNA-Human AIF1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AIF1
GTTS-WK15505MR IVTScrip™ mRNA-Human ANKRD18DP, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD18DP
GTTS-WK21716MR IVTScrip™ mRNA-Human ARHGEF3, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF3
GTTS-WK20007MR IVTScrip™ mRNA-Human ANKRD20A12P, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD20A12P
GTTS-WK21203MR IVTScrip™ mRNA-Human ANKRD17, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANKRD17
GTTS-WK15669MR IVTScrip™ mRNA-Human AKIRIN1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AKIRIN1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →